Merrimack
Tim Surgenor is a seasoned professional in the life sciences sector with extensive experience in corporate development and leadership support. Currently a Partner at Red Sky Partners, LLC since April 2009, Tim also serves as a Consultant for Merrimack, having led their virtual operating team since 2019. Previous roles include Director at Precision Ventures and a member of Launchpad Venture Group, as well as Board of Directors Chair for Audit at Neurometrix. Tim's earlier positions include President and CEO of Cyberkinetics Neurotechnology Systems, Executive Vice President at Haemonetics, and President of Genzyme Tissue Repair. Tim holds an MBA from Harvard Business School and a BA in Biochemistry from Williams College.
This person is not in any offices
Merrimack
Merrimack is a fully integrated biopharmaceutical company that views cancer as a complex engineering challenge. Through systems biology, which brings together the fields of biology, computing and engineering, Merrimack aims to decrease uncertainty in d...